These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

741 related items for PubMed ID: 16226734

  • 1. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H, Xu J, Ji X, Yang X, Sun K, Liu X, Shen Y.
    Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
    [Abstract] [Full Text] [Related]

  • 2. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Su DL, Wang HJ, Ji XH, Li YY, Xuan HB, Heng C, Li YF.
    Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
    [Abstract] [Full Text] [Related]

  • 4. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M, van Lopik T, Limburg PC, Spronk PE, Jaegers SM, Aarden LA, Smeenk RJ, Kallenberg GG.
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [Abstract] [Full Text] [Related]

  • 5. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM, Taher TE, Isenberg DA, Mageed RA.
    Scand J Rheumatol; 2009 Oct; 38(2):112-20. PubMed ID: 19110660
    [Abstract] [Full Text] [Related]

  • 6. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
    Tinazzi E, Puccetti A, Gerli R, Rigo A, Migliorini P, Simeoni S, Beri R, Dolcino M, Martinelli N, Corrocher R, Lunardi C.
    Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
    [Abstract] [Full Text] [Related]

  • 7. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH, Zhang J, Cai Q, Zhao DB, Wang J, Guo PE, Liu L, Han XH, Shen Q.
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [Abstract] [Full Text] [Related]

  • 8. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V, Singh AP, Aggarwal A, Naik S, Misra R.
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [Abstract] [Full Text] [Related]

  • 9. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus.
    Liphaus BL, Kiss MH, Carrasco S, Goldenstein-Schainberg C.
    J Rheumatol; 2007 Jul; 34(7):1580-4. PubMed ID: 17516614
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
    Suzuki N, Ichino M, Mihara S, Kaneko S, Sakane T.
    Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
    [Abstract] [Full Text] [Related]

  • 11. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
    al-Janadi M, Raziuddin S.
    J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
    [Abstract] [Full Text] [Related]

  • 12. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
    Yang JH, Shen Q, Zhao DB, Cai Q, Han XH.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 02; 85(5):318-23. PubMed ID: 15854508
    [Abstract] [Full Text] [Related]

  • 13. Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis.
    Cipriani P, Fulminis A, Pingiotti E, Marrelli A, Liakouli V, Perricone R, Pignone A, Matucci-Cerinic M, Giacomelli R.
    J Rheumatol; 2006 Oct 02; 33(10):2003-14. PubMed ID: 17014016
    [Abstract] [Full Text] [Related]

  • 14. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.
    Li B, Bassiri H, Rossman MD, Kramer P, Eyuboglu AF, Torres M, Sada E, Imir T, Carding SR.
    J Immunol; 1998 Aug 01; 161(3):1558-67. PubMed ID: 9686624
    [Abstract] [Full Text] [Related]

  • 15. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S.
    Arthritis Rheum; 2008 Mar 01; 58(3):801-12. PubMed ID: 18311820
    [Abstract] [Full Text] [Related]

  • 16. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus.
    Tsai HF, Lai JJ, Chou AH, Wang TF, Wu CS, Hsu PN.
    Arthritis Rheum; 2004 Feb 01; 50(2):629-39. PubMed ID: 14872508
    [Abstract] [Full Text] [Related]

  • 17. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
    Amel-Kashipaz MR, Huggins ML, Lanyon P, Robins A, Todd I, Powell RJ.
    J Autoimmun; 2001 Sep 01; 17(2):155-63. PubMed ID: 11591124
    [Abstract] [Full Text] [Related]

  • 18. [Studies on Fas ligand expression in patients with systemic lupus erythematosus].
    Feng Y.
    Hokkaido Igaku Zasshi; 1997 Jul 01; 72(4):443-55. PubMed ID: 9266252
    [Abstract] [Full Text] [Related]

  • 19. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M.
    Anticancer Res; 2001 Jul 01; 21(4B):3053-9. PubMed ID: 11712810
    [Abstract] [Full Text] [Related]

  • 20. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J, Dong J, Li Y, Liu YQ, Yang J, Wu Y, Li L, Shen GX, Tan ZJ, Tu YT.
    J Eur Acad Dermatol Venereol; 2009 Apr 01; 23(4):433-7. PubMed ID: 19335730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.